These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5725847)

  • 41. Rabies antibody seroprotection rates among travelers in Nepal: "rabies seroprotection in travelers".
    Ranney M; Partridge R; Jay GD; Rozzoli DE; Pandey P
    J Travel Med; 2006; 13(6):329-33. PubMed ID: 17107424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Using ELISA to evaluate the serologic and epidemiologic effect following rabies vaccination].
    Song H; Li W; Shan L
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Jun; 15(3):162-4. PubMed ID: 7834693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rabies prevention--United States, 1984.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Jul; 33(28):393-402, 407-8. PubMed ID: 6429509
    [No Abstract]   [Full Text] [Related]  

  • 44. [Preventive rabies immunization--is simplification in view?].
    Putzi R; Lüthy R
    Schweiz Rundsch Med Prax; 1983 Dec; 72(50):1583-6. PubMed ID: 6669819
    [No Abstract]   [Full Text] [Related]  

  • 45. [On a case of rabies despite vaccination].
    Breining H; Beck G
    Med Welt; 1968 Aug; 35():1864-5. PubMed ID: 5728951
    [No Abstract]   [Full Text] [Related]  

  • 46. [Behavior of skin tests with anti-rabies vaccine and of serum neutralization during immunization].
    Pacheco GA; Aguiar A
    Rev Paul Med; 1965 May; 66(5):263-8. PubMed ID: 5845973
    [No Abstract]   [Full Text] [Related]  

  • 47. [Rabies prevention: comparison of methods].
    Zouari B; Hannachi A; Nacef T; Doua MB; Romdhane HB
    Tunis Med; 1980; 58(1-2):436-9. PubMed ID: 7210194
    [No Abstract]   [Full Text] [Related]  

  • 48. Post exposure rabies prophylaxis with Purified Verocell Rabies Vaccine: a study of immunoresponse in pregnant women and their matched controls.
    Sudarshan MK; Madhusudana SN; Mahendra BJ; Ashwathnarayana DH; Jayakumary M; Gangaboriah
    Indian J Public Health; 1999; 43(2):76-8. PubMed ID: 11243072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. One or three intradermal injections within one week for rabies pre-exposure immunization.
    Khawplod P; Wilde H; Sriaroon C; Chomchey P; Kamolthum T; Sitprija V
    Dev Biol (Basel); 2008; 131():393-401. PubMed ID: 18634501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis.
    Tantawichien T; Tantawichien T; Supit C; Khawplod P; Sitprija V
    Clin Infect Dis; 2001 Dec; 33(12):2085-7. PubMed ID: 11712097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenicity study of abbreviated rabies preexposure vaccination schedules.
    Khawplod P; Wilde H; Benjavongkulchai M; Sriaroon C; Chomchey P
    J Travel Med; 2007; 14(3):173-6. PubMed ID: 17437473
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Anti-rabies vaccinations at the Institut Pasteur of Lyon in 1968].
    Lebeuf F
    Ann Inst Pasteur (Paris); 1969 Aug; 117(2):286-8. PubMed ID: 5406063
    [No Abstract]   [Full Text] [Related]  

  • 53. Studies on clinical trials and immune effect of a new purified rabies vaccine prepared from Vero cells.
    Dong G; Zheng H; Liu Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):19-23. PubMed ID: 11503018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group.
    Lang J; Simanjuntak GH; Soerjosembodo S; Koesharyono C
    Bull World Health Organ; 1998; 76(5):491-5. PubMed ID: 9868840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Intradermal administration of HDC vaccine in the immunization of people against rabies].
    Svjetlicić M; Ljubicić M; Baklaić Z; Smerdel S; Vodopija I
    Lijec Vjesn; 1984 Sep; 106(9):379-80. PubMed ID: 6503605
    [No Abstract]   [Full Text] [Related]  

  • 56. [Consensus paper on rabies vaccination for travelers].
    Schönfeld C
    MMW Fortschr Med; 2004 Apr; 146(16):53. PubMed ID: 15222503
    [No Abstract]   [Full Text] [Related]  

  • 57. [Epidemiologic aspects of the treatment of human rabies in Belo Horizante, Minas Gerais, Brazil].
    Moreira EC; Gontijo MT; Castro A; Reis R; Viana FC; Moreira WL
    Bol Oficina Sanit Panam; 1976 Jan; 80(1):38-44. PubMed ID: 129140
    [No Abstract]   [Full Text] [Related]  

  • 58. [Antirabies vaccinations at the Institut Pasteur de Lyon in 1967].
    Lebeuf F
    Ann Inst Pasteur (Paris); 1968 Aug; 115(2):305-7. PubMed ID: 5679340
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antirabies vaccinations at the Institut Pasteur in 1967].
    Lépine P; Atanasiu P; Gamet A; Vieu JF; Vialat C
    Ann Inst Pasteur (Paris); 1968 Aug; 115(2):297-304. PubMed ID: 5679339
    [No Abstract]   [Full Text] [Related]  

  • 60. [Preventive treatment after being exposed to rabies].
    Silva M
    Salud Publica Mex; 1974; 16(3):481-7. PubMed ID: 4453952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.